Update on radionuclide therapy in oncology.

about

Update on radionuclide therapy in oncology.

Item

http://www.wikidata.org/entity/Q47552162

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Update on radionuclide therapy in oncology.

@en

Update on radionuclide therapy in oncology.

@nl

type

Item

label

Update on radionuclide therapy in oncology.

@en

Update on radionuclide therapy in oncology.

@nl

prefLabel

Update on radionuclide therapy in oncology.

@en

Update on radionuclide therapy in oncology.

@nl

P1476

Update on radionuclide therapy in oncology.

@en

P2093

Ana Maria Popa

http://www.w3.org/2001/XMLSchema#string

Anca Mihaela Stoian Pantea

http://www.w3.org/2001/XMLSchema#string

Bianca Galateanu

http://www.w3.org/2001/XMLSchema#string

Bogdan Popescu

http://www.w3.org/2001/XMLSchema#string

Boris N Izotov

http://www.w3.org/2001/XMLSchema#string

Carolina Negrei

http://www.w3.org/2001/XMLSchema#string

Cornelia Nitipir

http://www.w3.org/2001/XMLSchema#string

Cristina Orlov

http://www.w3.org/2001/XMLSchema#string

Georgios Z Papadakis

http://www.w3.org/2001/XMLSchema#string

Maria Alexandra Barbu

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Nanoparticles and phage display selected peptides for imaging and therapy of cancer.

186Re-HEDP for metastatic bone pain in breast cancer patients.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.

Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report

P304

7011-7015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7141

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29344129

http://www.w3.org/2001/XMLSchema#string

P932

5754838

http://www.w3.org/2001/XMLSchema#string